AGAP2 and breast cancer: To date, some lncRNAs have been reported to be associated with breast cancer, for instance, AGAP2-AS1 (AGAP2 antisense RNA 1) promoted breast cancer stemness and trastuzumab resistance by controlling choline phosphotransferase 1-meidiated fatty acid oxidation [8].